Genetic analysis of developmental and epileptic encephalopathy caused by novel biallelic SZT2 gene mutations in three Chinese Han infants: a case series and literature review

Sai Yang,Li-Ming Yang,Hong-Mei Liao,Hong-Jun Fang,Ze-Shu Ning,Cai-Shi Liao,Li-Wen Wu
DOI: https://doi.org/10.1007/s10072-022-06038-3
2022-03-29
Neurological Sciences
Abstract:BackgroundDevelopmental and epileptic encephalopathy (DEE) exhibits phenotypic and genetic heterogeneity. Biallelic variants of the SZT2 gene can lead to DEE18, of which few cases have been reported. This study aimed to analyze the potential pathogenic factors in three cases of DEE18.MethodsTrio-whole exome sequencing and crystal structure simulation analysis were performed, along with a literature review of DEE18 cases.ResultsAll three patients had compound heterozygous variants in the SZT2 gene (patient 1, c.2887A > G/c.7970G > A; patient 2, c.3508A > G/c.7936C > T; and patient 3, c.2489G > T/c.8640_8641insC). The variants were predicted to have structural effects on the protein. Particularly, c.3508A > G/p.Ser1170Gly may lead to impaired binding of SZT2 to GATOR1, potentially resulting in the overactivation of the mTORC1 signaling pathway, causing seizures. Through the literature review, we observed that 27 patients with DEE had different degrees of intellectual and developmental disorders (DDs), and the variants leading to protein truncation cause severe DD and refractory epilepsy. Therefore, the phenotypic severity of patients may be related to the residual activity of variant SZT2 protein.ConclusionWe provide recently developed knowledge on the DEE18 genotype–phenotype spectrum and suggest that gene detection is of great value for the accurate diagnosis of patients with early-onset epilepsy. Further research is required for the development of individualized interventions for patients with DEE.
neurosciences,clinical neurology
What problem does this paper attempt to address?